Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?

[1]  P. Bossuyt,et al.  Predictive Value of Cervical Length Measurement and Fibronectin Testing in Threatened Preterm Labor , 2014, Obstetrics and gynecology.

[2]  P. Seed,et al.  Endocervical and high vaginal quantitative fetal fibronectin in predicting preterm birth , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[3]  P. Bossuyt,et al.  Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor. , 2013, American journal of obstetrics and gynecology.

[4]  E. DeFranco,et al.  Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. , 2013, American journal of obstetrics and gynecology.

[5]  P. Seed,et al.  Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. , 2013, American journal of obstetrics and gynecology.

[6]  Deborah M Caldwell,et al.  Tocolytic therapy for preterm delivery: systematic review and network meta-analysis , 2012, BMJ : British Medical Journal.

[7]  B. Mol,et al.  Time to delivery after the first course of antenatal corticosteroids: a cohort study. , 2011, American journal of perinatology.

[8]  Yvonne Vergouwe,et al.  Development and validation of a prediction model with missing predictor data: a practical approach. , 2010, Journal of clinical epidemiology.

[9]  S. Papatheodorou,et al.  Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta‐analysis , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[10]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[11]  B. Brost,et al.  Cost-effective standardization of preterm labor evaluation. , 2009, American journal of obstetrics and gynecology.

[12]  B. Mol,et al.  Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial) , 2009, BMC pregnancy and childbirth.

[13]  J. Zamora,et al.  Fetal Fibronectin as a Short-Term Predictor of Preterm Birth in Symptomatic Patients: A Meta-Analysis , 2009, Obstetrics and gynecology.

[14]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: Developing a prognostic model , 2009, BMJ : British Medical Journal.

[15]  Roberto Romero,et al.  Epidemiology and causes of preterm birth , 2008, The Lancet.

[16]  Charles E McCulloch,et al.  Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.

[17]  T. Stijnen,et al.  Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.

[18]  A Rogier T Donders,et al.  Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. , 2006, Journal of clinical epidemiology.

[19]  G. Mason,et al.  Severe hypotension and fetal death due to tocolysis with nifedipine , 2005, BJOG : an international journal of obstetrics and gynaecology.

[20]  William C Miller,et al.  The epidemiology of threatened preterm labor: a prospective cohort study. , 2005, American journal of obstetrics and gynecology.

[21]  R. Romero,et al.  Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. , 2005, American journal of obstetrics and gynecology.

[22]  S. Wen,et al.  Epidemiology of preterm birth and neonatal outcome. , 2004, Seminars in fetal & neonatal medicine.

[23]  J. Newnham,et al.  Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. , 2004, American journal of obstetrics and gynecology.

[24]  Ewout W Steyerberg,et al.  Internal and external validation of predictive models: a simulation study of bias and precision in small samples. , 2003, Journal of clinical epidemiology.

[25]  N. Uldbjerg,et al.  Preterm delivery , 2005, Acta obstetricia et gynecologica Scandinavica.

[26]  H. Brölmann,et al.  Myocardial infarction during nifedipine therapy for preterm labor. , 1999, The New England journal of medicine.

[27]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[28]  S Greenland,et al.  A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.

[29]  M. Holland,et al.  The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions. , 1995, American journal of obstetrics and gynecology.

[30]  T. Blaschke,et al.  Nifedipine pharmacokinetics during preterm labor tocolysis , 1989, American journal of obstetrics and gynecology.

[31]  A. A. Knecht.  EVALUATION OF A , 1972 .

[32]  D. Cabrol,et al.  Pharmacokinetics of Tocolytic Agents , 2004, Clinical pharmacokinetics.